| REVIEW ARTICLE |
|
| Year : 2016 | Volume
: 61
| Issue : 6 | Page : 583-587 |
|
|
Safety of topical medications for scabies and lice in pregnancy
Viral M Patel, W Clark Lambert, Robert A Schwartz
Dermatology and Pathology, Rutgers New Jersey Medical School and the Rutgers University School of Public Affairs and Administration Newark, New Jersey, USA
Correspondence Address:
Robert A Schwartz
Professor & Head, Dermatology, Rutgers New Jersey Medical School, 185 South Orange Avenue, Medical Science Building H-576, Newark, New Jersey 07103-2757
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-5154.193659
|
|
|
Medications should be employed with caution in women of childbearing age. Topical medications have little systemic absorption. Therefore, they are considered safer than oral or parenteral agents and less likely to be embryotoxic or fetotoxic. However, their safety profile must be assessed cautiously as the available data are limited. In this article, we aggregate human and animal studies to provide recommendations on using topical anti-scabies and anti-lice therapy in pregnancy. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
